Evaluation of Natalizumab for thE Relief of MS Associated FatiGue

CompletedOBSERVATIONAL
Enrollment

89

Participants

Timeline

Start Date

August 1, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Multiple Sclerosis
Trial Locations (31)

10003

Research Site, New York

11772

Research Site, Patchogue

14203

Research Site, Buffalo

25301

Research Site, Charleston

27262

Research Site, High Point

27599

Research Site, Chapel Hill

27607

Research Site, Raleigh

29621

Research Site, Anderson

30327

Research Site, Atlanta

37064

Research Site, Franklin

37205

Research Site, Nashville

37212

Research Site, Nashville

37934

Research Site, Knoxville

40202

Research Site, Louisville

40503

Research Site, Lexington

46256

Research Site, Indianapolis

48334

Research Site, Farmington Hills

50314

Research Site, West Des Moines

53188

Research Site, Waukesha

60010

Research Site, Lake Barrington

60201

Research Site, Evanston

83404

Research Site, Idaho Falls

84103

Research Site, Salt Lake City

84108

Research Site, Salt Lake City

85006

Research Site, Phoenix

93720

Research Site, Fresno

97225

Research Site, Portland

98195

Research Site, Seattle

02135

Research Site, Boston

02421

Research Site, Lexington

00969

Research Site, Guaynabo

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Elan Pharmaceuticals

INDUSTRY

lead

Biogen

INDUSTRY